Specifically designed for stem cells extraction
AXP® II Automated Processing System
FDA Cleared & Adopted Widely in Globe
Individual sterile processing to avoid sample mix-up
18% higher than other systems in stem cells extraction16
AXP® II Automated Processing System
Highest Cells Extraction Rate in Globe
HealthBaby uses the advanced AXP® II automated processing system that has received the FDA clearance, and complies with current good tissue practices (cGTP) and good manufacturing practices (GMP). Globally, the system has already processed over a million cord blood units to date. Designed to provide high-quality stem cell concentration from cord blood, the AXP® II system has demonstrated viable CD34+ stem cell recovery of more than 97%16 that is higher than most other known available systems. It is also a functionally closed processing system which ensures the sterility of the cord blood by eliminating exposure to air contaminants.
- Produced by U.S. Cesca Therapeutics (Netcord official partner), FDA cleared and highly compatible with BioArchive®
- The only automated processing system specially designed for stem cells harvesting
- Automated closed system, individual sterile processing to avoid sample mix-up
- Globally, the system has already processed over a million cord blood units to date31
- AXP® II system has demonstrated viable CD34+ stem cell recovery of more
than 97%16 that is higher than most other known available systems - XpressTRAK™ software compatible with international ISBT barcode for global information tracking
- The success of transplantation is determined by the quantity and viability of stem cells
Specificity
- FDA(USA), CE(Europe) and CSA(Canada) cleared. The highest quality standards including FACT and AABB attained
- The latest automated sterile processing system, specifically designed for stem cells harvesting
- Seamless compatibility with BioArchive® System ensuring long-term storage of the maximum number of stem cells
- Not specific for umbilical cord blood processing
Stem Cells Retrieval Rate
- AXP® II system has demonstrated viable CD34+ stem cell recovery of more
than 97% that is higher than most other known available systems16 - Retrieves only 79.9% MNC and 80.3% TNC, audited by U.S. Obstetrics & Gynaecology Society and Cord Blood Registry(The Largest Cord Blood Bank in U.S.)16
Recall Problem
- In response to the AXP® recall in 2008, this was due to the raw materials problems of the bagset manufacturing, not related to safety issue and AXP®II operation. However, the “Plan for Voluntary Recall” was highly appreciated by FDA, which the action was not a forcible recall20,21
Operation
- Closed independent processing system, eradicating contamination
- Automated processing in 45 minutes. Suitable for cord blood banks with high capacity
- High sensitivity
- XpressTRAK™ software provides real time and accurate data processing
- Compatible with ISBT barcode for global information tracking
- Over 65 minutes processing time, only for cord blood banks with low capacity
- Prolonged processing time will delay the processing of other cord blood samples and stem cells viability will be affected
Global Usage
- Most used automated cord blood processing system in both Asia and US regions30
- Most used by the largest cord blood bank, including New York Blood Center and Cord Blood Registry (The Largest Cord Blood Bank in U.S.)
- Most users shifted to use AXP® to enhance stem cells retrieval rate30
- Official collaborator of NETCORD organization
- Processed over 1,000,000 cord blood samples30
- Over 40 countries
Most Asked Questions by Parents Related to Cord Blood Banking
Until today, up to 113 diseases had been treated with cord blood transplants5. They could be divided into 7 categories, namely: Leukemia, Lymphomas, other Disorders of Blood Cell Proliferation, Inherited Disorders of Immune System, Inherited Metabolic Disorders, other Cancers and others.
Cord blood and umbilical blood contain two different stem cells which are widely adopted in different medical aspects. Cord blood is a rich source of HSCs which can create the blood and immune cells. Cancers, blood-related, immunity and metabolic diseases can be treated by cord blood. Umbilical cord is a rich source of MSCs which can create structural and connective tissues. Apart from minimizing GvHD in directed and unrelated allogeneic cord blood transplants, MSCs can potentially apply to chronic illnesses treatment, regenerative medicines as well as organ and tissue engineering5,6. Since cord blood and umbilical cord are rich sources of different types of stem cells, they may help to repair the body in different ways.
Entrusted by most parents in Hong Kong1, HealthBaby has a very comprehensive service coverage. Apart from the traditional liquid nitrogen storage plan, HealthBaby also pioneered to provide the advanced BioArchive® System. All storage plan of HealthBaby adopts the expensive liquid nitrogen as storage medium to provide the most stable tempertature for stem cell viability, providing the most quality umbilical cord and cord blood storage service.
To cater for different needs of clients, HealthBaby's cord blood and umbilical cord storage plan have very flexible and comprehensive service plan. Regarding cord blood plan, clients could select the storage plan base on the storage and processing system needs.
The umbilical cord and cord blood service fee already includes registration fee, processing fee and 18 years storage fee, no any additional charge during the contracted year. Extra discounted would be provided for registering both umbilical cord and cord blood storage plan. HealthBaby existing customers and other cord blood bank customers could also enjoy special offers. Please contact us for deatils and any enquiries.
For more details of cord blood service plan please refer to Service Plan.
More Questions?
Contact us through any method below:
Hotline: (+852)3188-8899 / (+853)2878-6717
WhatsApp: (+852)9660-8271 or Click Here
WeChat Official Account: HealthBaby 生寶臍帶血庫
Online: Click here to submit the enquiry online
Email: enquiry@healthbaby.hk